Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa

AIDS Research and Therapy

Volumn 7, Issue , 2010, Pages

  Ramjee, Gita ^a   Coumi, Nicola ^a   Dladla Qwabe, Nozizwe ^a   Ganesh, Shay ^a   Gappoo, Sharika ^a   Govinden, Roshini ^a   Guddera, Vijayanand ^a   Maharaj, Rashika ^a   Moodley, Jothi ^a   Morar, Neetha ^a   Naidoo, Sarita ^a   Palanee, Thesla ^a  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAREGIVER SUPPORT; CLINICAL RESEARCH; COMMUNITY CARE; CONTRACEPTION; DEVELOPING COUNTRY; FEMALE; HEALTH BELIEF; HEALTH PROGRAM; HELP SEEKING BEHAVIOR; HIGH RISK POPULATION; HIV EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; INFECTION RISK; INFORMATION DISSEMINATION; INFORMED CONSENT; MARITAL THERAPY; PAPANICOLAOU TEST; PATIENT ATTITUDE; PATIENT CARE; PATIENT COUNSELING; PATIENT PARTICIPATION; PATIENT REFERRAL; PEER GROUP; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; RESEARCH ETHICS; RISK REDUCTION; SAFE SEX; SEROCONVERSION; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SOCIAL SUPPORT; SOUTH AFRICA; WOMEN'S HEALTH;

EID: 77951135445     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-7-10     Document Type: Article

References (29)

1. UNAIDS Report on the global AIDS epidemic 2008, Geneva: Joint United Nations Programme on HIV/AIDS, UNAIDS.
2. Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, Pillay-Van-Wyk V, Mbelle N, Van Zyl J, Parker W, Zungu NP, Pezi S, . the SABSSM III Implementation Team South African national HIV prevalence, incidence, behaviour and communication survey 2008: A turning tide among teenagers? 2009, Cape Town: HSRC Press, the SABSSM III Implementation Team.
3. Rehle T, Shisana O, Pillay V, Zuma K, Puren A, Parker W. National HIV incidence measures - new insights into the South African epidemic. S Afr Med J 2007, 97:194-199.
4. Department of Health 2008 National antenatal sentinel HIV and syphilis prevalence survey, South Africa. 2009, Pretoria: National Department of Health, Department of Health.
5. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial. PLoS Med 2005, 2:e298. 10.1371/journal.pmed.0020298, 1262556,1262556, 16231970.
6. Update on the STEP and Phambili HIV vaccine trials. , http://www.saavi.org.za/pressreleases.htm
7. Abdool Karim S, Coletti A, Richardson B, Ramjee G, Hoffman I, Chirenje M, Taha T, Kapina M, Maslankowski L, Soto-Torres L. Safety and effectiveness of vaginal microbicides BufferGel and 0.5% PRO 2000 gel for the prevention of HIV infection in women: Results of the HPTN 035 trial [Abstract 48LB]. 16th Conference on Retroviruses and Opportunistic Infections; Montreal, Canada, 8-11 February 2009,
8. Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos M, Friedland B, Govender S, Dekock A, Cassim N, Palanee T. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: A randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:1977-1987. 10.1016/S0140-6736(08)61842-5, 19059048.
9. van Damme L, Govinden R, Mirembe F, Guédou F, Solomon S, Becker M, Pradeep BS, Krishnan AK, Alary M, Pande B, Ramjee G, Deese J, Crucitti T, Taylor D, . Group TCS Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med 2008, 359:463-472. 10.1056/NEJMoa0707957, 18669425, Group TCS.
10. Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan J. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of Human Immunodeficiency Virus type 1. J Infect Dis 2003, 187:725-735. 10.1086/367898, 12599045.
11. Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia H, . The South African Vitamin ASG Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. AIDS 1999, 13:1517-1524. 10.1097/00002030-199908200-00012, 10465076, The South African Vitamin ASG.
12. Padian N, Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Montgomery E, Fancher H, Cheng H. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: A randomised controlled trial. Lancet 2007, 370:251-261. 10.1016/S0140-6736(07)60950-7, 2442038, 17631387.
13. Jewkes R, Nduna M, Levin J, Jama N, Dunkle K, Puren A, Duvvury N. Impact of Stepping Stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: Cluster randomised controlled trial. BMJ 2008, 337:a506. 10.1136/bmj.a506, 2505093, 18687720.
14. Microbicides Development Programme. , http://www.mdp.mrc.ac.uk/index.html
15. Ramjee G, Govinden R, Morar N, Mbewu A. South Africa's experience of the closure of the Cellulose Sulphate microbicide trial. PLoS Med 2007, 4:e235. 10.1371/journal.pmed.0040235, 1950203, 17685664.
16. Woodsong C, MacQueen K, Namey E, Sahay S, Morar N, Mlingo M, Mehendale S. Women's autonomy and informed consent in microbicides clinical trials. Journal of Empirical Research on Human Research Ethics 2006, 1:11-26. 10.1525/jer.2006.1.3.11, 19385819.
17. Phillip J, Morar NS, Ramjee G. Assessment of understanding of informed consent process in the Microbicide Development Programme Feasibility study - Durban, South Africa. Microbicides 2006 2006, Cape Town, South Africa.
18. Ramjee G, Morar N, Alary M, Mukenge-Tshibaka L, Vuylsteke B, Ettiègne-Traoré V, Chandeying V, Karim S, Van Damme L, . on behalf of the COLsg Challenges in the conduct of vaginal microbicide effectiveness trials in the developing world. AIDS 2000, 14:2553-2557. 10.1097/00002030-200011100-00018, 11101067, on behalf of the COLsg.
19. Lince N, Blanchard K, Straten A, Watadzaushe C, Nkala B, Gappoo S, Ramjee G, Bostrom A. Measuring recall and understanding of informed consent: Results from a randomized controlled trial of the diaphragm for HIV prevention. 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Cape Town, South Africa 2009,
20. Frimpong-Mansoh A. Culture and voluntary informed consent in African health care systems. Developing World Bioethics 2008, 8:104-114. 10.1111/j.1471-8847.2006.00181.x, 19143087.
21. Gappoo S, Montgomery E, Gerdts C, Naidoo S, Chidanyika A, Nkala B, Ramjee G. Novel strategies implemented to ensure high participant retention rates in a community based HIV prevention effectiveness trial in South Africa and Zimbabwe. Contemporary Clinical Trials 2009,
22. Seedat M, Van Niekerk A, Jewkes R, Suffla S, Ratele K. Violence and injuries in South Africa: Prioritising an agenda for prevention. Lancet 2009, 374:1011-1022. 10.1016/S0140-6736(09)60948-X, 19709732.
23. Cassim N, Kizis F, Ahmed K, Skoler S, Ramjee G, Altini L, Lahteenmaki P, Palanee T, Thebe T, Patel S. The prevalence of abnormal pap smear lesions in HIV positive and negative women screened for the phase 3 trial of Carraguard [Abstract PA10]. Microbicides 2006 2006, Cape Town, South Africa.
24. Luthuli D, Vasant U, Asmal H, Govinden R, Ramjee G. Prevalence of abnormal pap smears among high risk women participating in a phase III cellulose sulphate trial [Abstract PB39]. Microbicides 2006 2006, Cape Town, South Africa.
25. Naidoo K, Dorsamy E, Naidoo B, Munsami C, Gumede K, Govinden R, Ramjee G. Preventing co-enrolment in multiple clinical trials in Durban, South Africa [Abstract PB54]. Microbicides 2006 2006, Cape Town, South Africa.
26. Milford C, Straten A, Clouse K, Blanchard K, Ramjee G. Access to care in HIV prevention trials: The MIRA standard of care programme, Durban, South Africa [Abstract WEPEC046]. 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Sydney, Australia 2007,
27. HIV 'prevention' gel PRO 2000 proven ineffective. , http://www.mdp.mrc.ac.uk/archive.html
28. Celum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Casapia M, Ortiz A, Fuchs J. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: A randomised, double-blind, placebo-controlled trial. Lancet 2008, 371:2109-2119. 10.1016/S0140-6736(08)60920-4, 2650104, 18572080.
29. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, Baeten JM, Mullins JI, Hughes JP, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie J, Farquhar C, Stewart GJ, Makhema J, Essex M, Were E, Fife KH, de Bruyn G, Gray GE, McIntyre JA, Manongi R, Kapiga S, Coetzee D, Allen S, Inambao M, Kayitenkore K, Karita E, Kanweka W, Delany S, Rees H, Vwalika B, Stevens W, Campbell MS, Thomas KK, Coombs RW, Morrow R, Whittington WLH, McElrath MJ, Barnes L, Ridzon R, Corey L, . the Partners in Prevention HSV/HIV Transmission Study Team Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010, 362:427-439. 10.1056/NEJMoa0904849, 2838503, 20089951, the Partners in Prevention HSV/HIV Transmission Study Team.